TY - JOUR
T1 - Associations of seroreactivity against crystallin proteins with disease activity and cataract in patients with uveitis
AU - Chen, Ling
AU - Holland, Gary N.
AU - Yu, Fei
AU - Levinson, Ralph D.
AU - Lampi, Kirsten J.
AU - Horwitz, Joseph
AU - Gordon, Lynn K.
PY - 2008/10
Y1 - 2008/10
N2 - PURPOSE. βB1-crystallin is a putative target of an autoantibody observed in a subset of patients with uveitis. The purpose of this study was to determine whether seroreactivity against βB1 or other specific purified crystallin proteins is observed in patients with uveitis and whether this reactivity is associated with either cataract or active intraocular inflammation. METHODS. Sera from patients with uveitis were tested for IgG antibodies with reactivity against αA-, αB-, βB1-, or βB2-crystallin proteins using a modified slot-blot protocol. Ophthalmic evaluations included analysis of the degree of intraocular inflammation and assessment of lens opacity by the Lens Opacities Classification System (LOCS) III. Positive anti-crystallin reactivity was defined as greater than the mean + 2 SD of the reactivity of a commercially available control serum panel. Statistical analysis was performed with the Fisher exact test, Kruskal-Wallis test, and Student's t-test. RESULTS. IgG antibodies against αA-, αB-, or βB1-crystallin were identified in 70% of 39 subjects; in contrast, only 30% of the control sera exhibited reactivity against one or more of these crystallin proteins (P le; 0.01). Seroreactivity against αA-, αB-, or βB1-, but not βB2-crystallin was related to active anterior segment inflammation. Seroreactivity against αB and βB1 was significantly related to cortical cataract (P ≤ 0.05). CONCLUSIONS. Serum antibodies against specific crystallin proteins are present in most patients with uveitis. The relationship between the presence of specific anti-crystallin antibodies and active inflammation may indicate a role for these autoantibodies in uveitis pathogenesis.
AB - PURPOSE. βB1-crystallin is a putative target of an autoantibody observed in a subset of patients with uveitis. The purpose of this study was to determine whether seroreactivity against βB1 or other specific purified crystallin proteins is observed in patients with uveitis and whether this reactivity is associated with either cataract or active intraocular inflammation. METHODS. Sera from patients with uveitis were tested for IgG antibodies with reactivity against αA-, αB-, βB1-, or βB2-crystallin proteins using a modified slot-blot protocol. Ophthalmic evaluations included analysis of the degree of intraocular inflammation and assessment of lens opacity by the Lens Opacities Classification System (LOCS) III. Positive anti-crystallin reactivity was defined as greater than the mean + 2 SD of the reactivity of a commercially available control serum panel. Statistical analysis was performed with the Fisher exact test, Kruskal-Wallis test, and Student's t-test. RESULTS. IgG antibodies against αA-, αB-, or βB1-crystallin were identified in 70% of 39 subjects; in contrast, only 30% of the control sera exhibited reactivity against one or more of these crystallin proteins (P le; 0.01). Seroreactivity against αA-, αB-, or βB1-, but not βB2-crystallin was related to active anterior segment inflammation. Seroreactivity against αB and βB1 was significantly related to cortical cataract (P ≤ 0.05). CONCLUSIONS. Serum antibodies against specific crystallin proteins are present in most patients with uveitis. The relationship between the presence of specific anti-crystallin antibodies and active inflammation may indicate a role for these autoantibodies in uveitis pathogenesis.
UR - http://www.scopus.com/inward/record.url?scp=53449094940&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=53449094940&partnerID=8YFLogxK
U2 - 10.1167/iovs.08-1971
DO - 10.1167/iovs.08-1971
M3 - Article
C2 - 18539933
AN - SCOPUS:53449094940
SN - 0146-0404
VL - 49
SP - 4476
EP - 4481
JO - Investigative Ophthalmology and Visual Science
JF - Investigative Ophthalmology and Visual Science
IS - 10
ER -